Current  Archive  
Renowned Endocrinologist Appointed Inaugural Chair Holder
Thursday, January 31, 2008 (2543 reads)

CLEVELAND – Leona Cuttler, MD, Chief of Endocrinology, Diabetes, and Metabolism and Director of the Center for Child Health & Policy at University Hospitals Rainbow Babies & Children’s Hospital has been appointed as the inaugural chair holder of the William T. Dahms Chair in Pediatric Endocrinology.

Dr. Dahms worked at Rainbow as a pediatric endocrinologist for 28 years, before passing away in 2006. His career was dedicated to clinical research, primarily in childhood diabetes, and he was division chief of pediatric endocrinology for several years. The chair was established in recognition of Dr. Dahms’ long-standing commitment and devotion to caring for children with endocrine disorders. Dr. Dahms recruited Dr. Cuttler to Cleveland in 1990.

“William Dahms was a wonderful person and a great endocrinologist. I have unbounded respect for what he brought to Rainbow, to the Division of Endocrinology, and to the field.” said Dr. Cuttler. “This chair, in his name, is a great honor for me.”



UH Rainbow Babies and Childrens HospitalRead More
Diuretics Appear Comparable or Better Than Other Drugs for Treating Hypertension in Patients With Metabolic Syndrome
Monday, January 28, 2008 (1631 reads)

CHICAGO – Use of calcium-channel blockers, alpha-blockers or angiotensin-converting enzyme (ACE) inhibitors appears to offer no advantages in improving clinical outcomes compared with use of diuretics when treating hypertension among individuals with metabolic syndrome, according to a report in the January 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. This appears particularly true for black patients.

Patients with hypertension (high blood pressure) and metabolic syndrome are at high risk for the complications of cardiovascular disease, according to background information in the article. The metabolic syndrome was defined as hypertension plus at least two of the following factors: diabetes or pre-diabetes; a body mass index (BMI) of at least 30; high triglyceride levels; or low levels of high-density lipoprotein (“good” cholesterol). Because some medications for high blood pressure (including alpha-blockers, ACE inhibitors and calcium channel blockers) have a favorable metabolic profile—for instance, have more favorable short-term effects on blood glucose or blood cholesterol levels—they have been advocated over other drugs (beta-blockers and diuretics) for the treatment of patients with metabolic syndrome.

Jackson T. Wright Jr., M.D., Ph.D., of University Hospitals Case Medical Center and Case Western Reserve University, Cleveland, and colleagues analyzed data from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).



UH Case Medical CenterRead More
University Hospitals Celebrates New Twinsburg Health Center With Community Open House
Sunday, January 27, 2008 (1939 reads)

CLEVELAND – University Hospitals Twinsburg Health Center will hold a community open house on January 29, from 4:30 to 6:30 p.m., to celebrate the opening of its new, state-of-the-art outpatient health center in Twinsburg. The Twinsburg Health Center, which is the first completed building project of UH’s Vision 2010 strategic plan, is located at 8819 Commons Boulevard, off Route 82.

At the open house, UH will offer free health screenings, including blood pressure, blood sugar, blood type, body fat index for children, and cholesterol. Visitors also will enjoy refreshments, give-aways, and tours of the facility. The UH MedEvac helicopter and members of the critical care flight team will be on site.



UH Case Medical CenterRead More
University Hospitals and Case Western Reserve University Department of Ophthalmology and Visual Sciences Awarded Funds for Vision-threatening Conditions
Monday, January 21, 2008 (1739 reads)

CLEVELAND – The Department of Ophthalmology and Visual Sciences at University Hospitals Case Medical Center and Case Western Reserve University has been awarded $110,000 in unrestricted funds by Research to Prevent Blindness, the world’s leading voluntary organization supporting eye research.

Under the direction of Jonathan H. Lass, M.D., the department has received grants totaling in excess of $1.6 million over the past 11 years.

“We are thrilled Research to Prevent Blindness continues to recognize and support our on-going research activities and the ever-changing world of vision science,” said Dr. Lass. “The funds will allow us to continue to identify the causes, treatment and prevention of blinding diseases such as corneal cataracts, macular degeneration, ocular inflammation and scarring, diabetic retinopathy and genetic eye diseases,” he added.



UH Case Medical CenterRead More